LOXL2 and head and neck squamous cell carcinoma: These results suggest that hypoxia-induced LOXL2 contributes to the invasion rather than to the proliferation of HNSCC cells; sEVs derived from hypoxic cancer cells can deliver increased LOXL2 protein to non-hypoxic cells to achieve a pseudo-hypoxia behavior.